A Randomised, Double Blind, Placebo-controlled, Parallel Group Trial of Low-dose Adjunctive alTeplase During prIMary PCI
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2017
At a glance
- Drugs Alteplase (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms T-TIME
- 12 Oct 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Jun 2018.
- 10 Jun 2017 Biomarkers information updated
- 24 Jun 2016 Status changed from discontinued to recruiting.